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Abstract
Background The Patient-reported Outcome Measurement
Information System (PROMIS) continues to be an important universal patient-reported outcomes measure (PROM)
in orthopaedic surgery. However, there is concern about
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the performance of the PROMIS as a general health questionnaire in hand surgery compared with the performance of
region- and condition-speciﬁc PROMs such as the Michigan
Hand Questionnaire (MHQ) and the Boston Carpal Tunnel
Questionnaire (BCTQ), respectively. To ensure that
PROMIS domains capture patient-reported outcomes to the
same degree as region- and condition-speciﬁc PROMs do,
comparing PROM performance is necessary.
Questions/purposes (1) Which PROMs demonstrate high
responsiveness among patients undergoing carpal tunnel
release (CTR)? (2) Which of the PROMIS domains
(Physical Function [PF], Upper Extremity [UE], and Pain
Interference [PI]) demonstrate concurrent validity with the
HHQ and BCTQ domains?
Methods In this prospective study, between November
2014 and October 2016, patients with carpal tunnel syndrome visiting a single surgeon who elected to undergo
CTR completed the BCTQ, MHQ, and PROMIS UE, PF,
and PI domains at each visit. A total of 101 patients agreed
to participate. Of these, 31 patients (31%) did not return
for a followup visit at least 6 weeks after CTR
and were excluded, leaving a ﬁnal sample of 70 patients
(69%). We compared the PROMIS against region- and
condition-speciﬁc PROMs in terms of responsiveness and
concurrent validity. Responsiveness was determined using
Cohen’s d or the effect-size index (ESI). The larger the
absolute value of the ESI, the greater the effect size. Using
the ESI allows surgeons to better quantify the impact of
CTR, with a medium ESI (that is, 0.5) representing a visible
clinical change to a careful observer. Concurrent validity
was determined using Spearman’s correlation coefﬁcient
with correlation strengths categorized as excellent (> 0.7),
excellent-good (0.61-0.70), good (0.4-0.6), and poor
(< 0.4). Signiﬁcance was set a priori at p < 0.05.

Results Among PROMIS domains, the PI demonstrated
the best responsiveness (ESI = 0.74; 95% CI, 0.39-1.08),
followed by the UE (ESI = -0.66; 95% CI, -1.00 to -0.31).
For the MHQ, the Satisfaction domain had the largest effect
size (ESI = -1.48; 95% CI, -1.85 to -1.09), while for the
BCTQ, the Symptom Severity domain had the best responsiveness (ESI = 1.54; 95% CI, 1.14-1.91). The
PROMIS UE and PI domains demonstrated excellent-good
to excellent correlations to the total MHQ and BCTQ–
Functional Status scores (preoperative UE to MHQ:
r = 0.68; PI to MHQ: r = 0.74; UE to BCTQ–Functional
Status: r = 0.74; PI to BCTQ–Functional Status: r = 0.67;
all p < 0.001), while the PROMIS PF demonstrated poor
correlations with the same domains (preoperative PF to
MHQ; r = 0.33; UE to BCTQ–Functional Status: r = 0.39;
both p < 0.01).
Conclusions The PROMIS UE and PI domains demonstrated slightly worse responsiveness than the MHQ and
BCTQ domains that was nonetheless acceptable. The
PROMIS PF domain was unresponsive. All three PROMIS
domains correlated with the MHQ and BCTQ, but the
PROMIS UE and PI domains had notably stronger correlations to the MHQ and BCTQ domains than the PF domain did. We feel that the PROMIS UE and PI can be used
to evaluate the clinical outcomes of patients undergoing
CTR, while also providing more robust insight into overall
health status because they are general PROMs. However,
we do not recommend the PROMIS PF for evaluating
patients undergoing CTR.
Level of Evidence Level II, diagnostic study.

Introduction
Recently, there has been an interest in using patientreported outcomes measures (PROMs) [1] as the US
healthcare system shifts towards focusing on value—
deﬁned as dollar spent per health outcome achieved [26].
The use of PROMs may help better align orthopaedic
surgeons’ expectations with clinical outcomes [8] and help
surgeons incorporate measures of patient-reported health
into treatment decisions to understand patients’ responses
to different treatments and understand who might clinically
beneﬁt from a given intervention [23, 29]. Within orthopaedic surgery, a number of validated, region-speciﬁc
PROMs have frequently been used in patient care [7, 18,
22, 30, 34]. However, more recently, there has been a new
movement towards universal PROMs as the push towards
population health increases. The Patient-reported Outcome
Measurement Information System (PROMIS) is a generic
PROM that incorporates item response theory and computerized adaptive testing [6]. One beneﬁt of the PROMIS
is that it captures constructs that are similar to those of
specialty-speciﬁc PROMs [2, 9, 10, 25, 28]. It is also

responsive; that is, the PROMIS’s domains can be used
detect change over time [13, 14, 16, 17, 19]. Although
studies in certain areas of orthopaedic surgery (such as
ACL reconstruction and spine disorders) show that the
PROMIS domains and region-speciﬁc scales have comparable responsiveness [19, 32], there is still concern that
the PROMIS Physical Function (PF), Upper Extremity
(UE), and Pain Interference (PI) domains are not sufﬁciently speciﬁc to the hand or certain hand procedures such
as carpal tunnel release (CTR). Because of concern that the
PROMIS PF domain is not responsive to hand conditions, a
PROMIS UE physical function scale was developed.
Studies documenting the responsiveness and concurrent
validity of the PROMIS in patients seeking hand care are
needed. An evaluation of responsiveness and concurrent
validity in a subset of patients seeking hand care, such as
those undergoing CTR, will offer much better insight into
common hand conditions. Patients undergoing CTR are an
ideal population to begin such an inquiry in because CTR is
common, with a lifetime prevalence of 3.1% [27], and CTR
is the only hand condition that can be evaluated with both a
region-speciﬁc PROM (Michigan Hand Questionnaire
[MHQ]) and a condition-speciﬁc PROM (Boston Carpal
Tunnel Questionnaire [BCTQ]). If the PROMIS is equally
responsive and valid as region-speciﬁc PROMs, the ﬁnancial investment in potentially improved patient care may be
worthwhile, because the PROMIS measures a patient’s
overall health and the impact of carpal tunnel syndrome
(CTS) instead of simply disease-speciﬁc effects [15].
Therefore, we asked: (1) Which PROMs demonstrate
high responsiveness among patients undergoing CTR? (2)
Which of the PROMIS domains (PF, UE, and PI) demonstrate concurrent validity with the MHQ and BCTQ
domains?

Patients and Methods
Study Design and Patient Sample
Between November 2014 and October 2016, patients
presenting to a single hand surgeon at a large, urban, academic medical center who had isolated CTS and wanted to
undergo CTR were asked to participate in this prospective,
institutional review board-approved study. The presence of
CTS was determined by taking the patient’s history and
performing a physical examination, and was conﬁrmed
with EMG testing. A total of 101 patients were willing to
participate. Of these, 31 patients (31%) were removed from
the ﬁnal sample because they did not attend a followup
clinic visit at least 6 weeks after undergoing CTR. This
left a ﬁnal sample of 70 patients (69%) for all analyses (Fig.
1). The average age was 61 years (range, 27-86 years) and
the majority were women (46; 66%) (Table 1). Most

patients (43; 61%) had a 6-week followup visit, while the
remainder (27 patients; 39%) had a 3-month followup visit.
The majority of operations were on the right wrist (43
patients; 61%).
Apple iPads (Apple, Cupertino, CA, USA) were used to
gather PROM data; this has been shown to be an efﬁcient
approach in a hand-surgery population [35]. Each patient
completed the following PROMs: the PROMIS PF, PI, and
UE domains; the BCTQ; and the MHQ, and the results
were collated using REDCap (Vanderbilt University,
Nashville, TN, USA). Patients completed all PROMs at
each visit during the study period. To allow for recovery
after CTR, we only included patients with PROM scores
from initial preoperative clinic visits and ﬁnal followup
clinic visits at 6 weeks or 3 months postoperatively.
Higher PROMIS PF and UE scores indicate better
physical function, while higher PROMIS PI scores denote
increased pain interference or physical limitations secondary to pain [5]. PROMIS domains follow a populationbased normal distribution, with a mean t-score of 50 and
standard deviation of 10 [11]. Unlike the other PROMs
used in this study, there is no total PROMIS score, because
each domain evaluates a different construct. For the
BCTQ–Total Score (average of the two BCTQ domains–
Functional Status Scale and Symptom Severity Scale),
which has a score ranging from 1 to 5, higher scores indicate worse symptom severity and physical function. For
the MHQ, which has a score ranging from 0 to 100, lower
scores indicate worse overall hand health.

Statistical Analysis
We calculated the patients’ characteristics. We also evaluated the three PROMIS domains (UE, PF, PI); eight MHQ
domains (Overall Hand Function, Activities of Daily

Living–One Hand, Activities of Daily Living–Two Hands,
Overall Activities of Daily Living, Ability to Work, Pain,
Aesthetic, and Satisfaction), in addition to the total score;
and two BCTQ domains (Symptom Severity Scale and
Functional Status Scale), in addition to the average of the
two domains (that is, the BCTQ–Total Score).
To evaluate the responsiveness of each PROM domain,
we used Cohen’s d, or the effect-size index (ESI), for all
changes in scores. The absolute value of each ESI was taken
because the size of the effect was of the most interest, not the
direction. The ESI is a frequently used index of change to
judge responsiveness, with higher values indicating improved responsiveness or better ability to detect change [20].
Responsiveness is important to evaluate for any PROM; for
example, if the instrument does not effectively identify clear
clinical improvement after CTR, then we cannot use that
particular PROM to evaluate the success or failure of CTR.
Values of 0.2, 0.5, and greater than 0.8 are considered small,
medium, and large effect sizes, respectively [20]. To put
these values into a clinical perspective, an ESI of 0.5 (that
is, a medium effect size) may be thought of as representing a
true change in patient status that is appreciated by a careful
observer [33]. In the current study, we evaluated the change
between the preoperative visit and longest followup postoperatively, either 6 weeks or 3 months.
Concurrent validity was evaluated using Spearman’s
correlation coefﬁcients (r) because the assumption of normality (Shapiro-Wilk test, skewness, kurtosis, and visual
assessment of histograms) was not met for all variables.
Absolute values were used because the strength, not the
direction of the correlation, indicates concurrent validity.
Spearman’s correlation coefﬁcients were calculated for each
preoperative PROMIS domain and MHQ domain (as well as
MHQ–Total Score) and each preoperative PROMIS domain
and BCTQ domain (as well as BCTQ–Total Score).
Spearman’s correlation coefﬁcients were also calculated for

Fig. 1 This diagram illustrates the pathway from the total possible patient sample agreeing
to participate in this prospective study to the ﬁnal patient sample used for all analyses.

Table 2. ESI values at ﬁnal followup

Table 1. Patient characteristics (n = 70)
Variable

Mean (SD)
or n (%)

Age, years
Sex, female
Operative side, right
Hand dominance, right
Followup
6 weeks
3 months

61 (14)
46 (66%)
43 (61%)
64 (91%)
43 (61%)
27 (39%)

each postoperative PROMIS domain and MHQ domain (as
well as MHQ–Total Score) and each postoperative PROMIS
and BCTQ domain (as well as BCTQ–Total Score). Using
guidelines from a previous study using the PROMIS [31],
we designated the strength of the Spearman’s correlations
for the total PROM scores as follows: excellent (> 0.7),
excellent-good (0.61-0.70), good (0.4-0.6), and poor (< 0.4).
Signiﬁcance was set a priori at p < 0.05.

Results
Responsiveness of Outcomes Tools
The PI domain of the PROMIS demonstrated the best responsiveness (ESI = 0.74; 95% CI, 0.39-1.08), followed by
the UE domain (ESI = -0.66; 95% CI, -1.00 to -0.31). For
the MHQ, the Satisfaction domain demonstrated the largest
effect size (ESI = -1.48; 95% CI, -1.85 to -1.09), followed
by the Total Score (ESI = -1.22; 95% CI, -1.58 to -0.84).
For the BCTQ, the Symptom Severity domain demonstrated the best responsiveness (ESI = 1.54; 95% CI,
1.14-1.91). All PROMs except for the PROMIS PF domain
(ESI = -0.25; 95% CI, -0.59 to 0.08) and MHQ Aesthetic
domain (ESI = 0.02; 95% CI, -0.32 to 0.36) demonstrated
at least a medium effect size at the ﬁnal followup examination (Table 2).

Concurrent Validity Among Outcomes Tools
Among the preoperative PROM scores, the PROMIS UE
and PI scores demonstrated concurrent validity (excellentgood and excellent correlations, respectively) with the
MHQ Total Score (UE: r = 0.68; p < 0.001; PI: r = 0.74;
p < 0.001, but the PROMIS PF score demonstrated a poor
correlation with the MHQ Total Score (r = 0.33; p = 0.006)
(Table 3). Preoperative PROMIS UE scores exhibited
good-to-excellent correlations with all preoperative
MHQ domain scores (range, UE: r = 0.41-0.80; all p <
0.001) except for the MHQ Aesthetics score (r = 0.24; p =

Scale
PROMIS
UE
PF
PI
MHQ
Overall Hand Function
Activities of Daily Living
Activities of Daily Living–Two Hands
Overall Activities of Daily Living
Ability to Work
Pain
Aesthetics
Satisfaction
Total Score
BCTQ
BCTQ–Symptom Severity Scale
BCTQ–Functional Status Scale
BCTQ–Total Score

ESI estimate
(95% CI)
-0.66 (-1.00 to -0.31)
-0.25 (-0.59 to 0.08)
0.74 (0.39-1.08)
-0.99 (-1.34 to -0.63)
-0.61 (-0.95 to -0.27)
-0.64 (-0.98 to -0.29)
-0.67 (-1.01 to -0.32)
-0.57 (-0.91 to -0.22)
1.17 (0.80-1.52)
0.02 (-0.32 to 0.36)
-1.48 (-1.85 to -1.09)
-1.22 (-1.58 to -0.84)
1.54 (1.14-1.91)
0.84 (0.49-1.19)
1.27 (0.90-1.63)

BCTQ = Boston Carpal Tunnel Questionnaire; MHQ = Michigan
Hand Questionnaire; PF = Physical Function; PI = Pain Interference;
PROMIS = Patient-reported Outcome Measurement Information
System; UE = Upper Extremity.

0.04) (Table 3). Likewise, preoperative PROMIS PI
scores exhibited good to excellent-good correlations with
all preoperative MHQ domain scores (UE: r = 0.53-0.69;
all p < 0.001) except for the MHQ Aesthetics score (r =
0.18; p = 0.15) (Table 3). For the PROMIS PF, correlations with the MHQ domains ranged from poor to good
(PF: r = 0.007-0.48; p = 0.95 to < 0.001) (Table 3).
Among preoperative PROM scores, the PROMIS UE and
PI demonstrated excellent and excellent-good correlations, respectively, with the BCTQ–Functional Status
domain (UE: r = 0.74; p < 0.001; PI: r = 0.67; p < 0.001),
while the PF demonstrated a poor correlation (PF:
r = 0.39; p = 0.001) (Table 3). The PROMIS UE and PI
domains also demonstrated good and excellent-good
correlations, respectively, with the BCTQ–Symptom
Severity scale (UE: r = 0.49; p < 0.001; PI: r = 0.69; p <
0.001), while the PF had a poor correlation (PF: r = 0.04;
p = 0.73) (Table 3).
Among postoperative PROM scores, the PROMIS UE
and PI scores demonstrated concurrent validity (excellentgood to excellent correlations, respectively) with the MHQ
Total Score (UE: r = 0.65; p < 0.001; PI: r = 0.72; p <
0.001) (Table 4). The PROMIS PF scores had a poor correlation with the MHQ Total Score (r = 0.36; p = 0.002)
(Table 4). Except for the MHQ Aesthetics domain (r =
0.007; p = 0.96), postoperative PROMIS UE scores

Table 3. Spearman’s correlation coeﬃcient for the preoperative PROMIS, MHQ, and BCTQ domain scores (n = 70)
PROMIS domain
PROM

MHQ or BCTQ domain

UE

PF

PI

MHQ

Overall Hand Function
p value
Activities of Daily Living
p value
Activities of Daily Living–Two Hands
p value
Overall Activities of Daily Living
p value
Ability to Work
p value
Pain
p value
Aesthetics
p value
Satisfaction
p value
Total Score
p value
BCTQ–Symptom Severity Scale
p value
BCTQ–Functional Status Scale
p value

0.52
< 0.001
0.58
< 0.001
0.80*
< 0.001
0.73*
< 0.001
0.65*
< 0.001
0.41
< 0.001
0.24
0.040
0.45
< 0.001
0.68*
< 0.001
0.49
< 0.001
0.74*
< 0.001

0.34
0.004
0.41
0.001
0.48
< 0.001
0.45
< 0.001
0.40
0.001
0.007
0.950
0.21
0.080
0.24
0.050
0.33
0.006
0.04
0.730
0.39
0.001

0.53
< 0.001
0.56
< 0.001
0.63*
< 0.001
0.64*
< 0.001
0.69*
< 0.001
0.65*
< 0.001
0.18
0.150
0.59
< 0.001
0.74*
< 0.001
0.69*
< 0.001
0.67*
< 0.001

BCTQ

*Denotes an excellent to excellent-good correlation. BCTQ = Boston Carpal Tunnel Questionnaire; MHQ = Michigan Hand
Questionnaire; PROM = patient-reported outcomes measure; PROMIS = Patient-reported Outcome Measurement Information
System.

exhibited good to excellent-good correlations with all other
preoperative MHQ domain scores (UE: r = 0.53-0.69; all
p < 0.001) (Table 4). Except for the MHQ Aesthetics domain (r = 0.09; p = 0.48), postoperative PROMIS PI scores
exhibited good-to-excellent correlations with all other
preoperative MHQ domain scores (UE: r = 0.54-0.72; all
p < 0.001) (Table 4). For the PROMIS PF, only the correlation with MHQ Overall Hand Function, Activities of
Daily Living–Two Hands, and Overall Activities of Daily
Living was above poor (PF: r = 0.40-0.44; all p < 0.05)
(Table 4). The PROMIS UE and PI domains also demonstrated excellent and excellent-good correlations, respectively, with the BCTQ–Symptom Severity domain
(UE: r = 0.74; p < 0.001; PI: r = 0.62; p < 0.001), while the
PF domain had a good correlation (PF: r = 0.40; p = 0.008).
Similarly, for the BCTQ–Functional Status scale postoperatively, the PROMIS UE and PI also demonstrated
excellent and excellent-good correlations, respectively
(UE: r = 0.75; p < 0.001; PI: r = 0.66; p < 0.001). The
PROMIS PF domain had a poor correlation with the
BCTQ–Functional Status domain postoperatively (PF:
r = 0.37; p = 0.002) (Table 4).

Discussion
PROMs, especially generic instruments such as the
PROMIS, are becoming common in orthopaedic clinics with
an increasing interest in value-based health care. In many
orthopaedic settings, the PROMIS, which may add more
value than other PROMs because of its ability to provide
insight into a patient’s overall health in the setting of illness,
has been shown to capture constructs that are similar to those
of more focused PROMs (such as region-speciﬁc PROMs)
[2, 9, 10, 25, 28] with comparable responsiveness [13, 16,
17, 19]. However, it is unclear if this is consistent within a
patient population that has a single, common hand condition
(that is, CTS) treated with the same procedure (CTR). The
ﬁndings of this study suggest that the PROMIS UE and PI
scores effectively detect change in patients undergoing
CTR; however, region- and disease-speciﬁc scales
demonstrated a greater ability to detect change than the
PROMIS did. Overall, we found the PROMIS UE and PI
scales to be moderately responsive and valid in capturing
information on the outcomes of patients undergoing CTR,
while the PROMIS PF is neither responsive nor valid for this

Table 4. Spearman’s correlation coeﬃcients for the postoperative PROMIS, MHQ, and BCTQ domain scores (n = 70)
PROMIS domain
PROM

MHQ or BCTQ domain

UE

PF

PI

MHQ

Overall Hand Function
p value
Activities of Daily Living
p value
Activities of Daily Living–Two Hands
p value
Overall Activities of Daily Living
p value
Ability to Work
p value
Pain
p value
Aesthetics
p value
Satisfaction
p value
Total Score
p value
BCTQ
p value
BCTQ–Functional Status
p value

0.57
< 0.001
0.61*
< 0.001
0.69*
< 0.001
0.69*
< 0.001
0.64*
< 0.001
0.54
< 0.001
0.007
0.960
0.53
< 0.001
0.65*
< 0.001
0.74*
< 0.001
0.75*
< 0.001

0.40
< 0.001
0.37
0.002
0.45
< 0.001
0.44
< 0.001
0.35
0.003
0.17
0.170
0.05
0.670
0.38
0.001
0.36
0.002
0.40
< 0.001
0.37
0.002

0.65*
< 0.001
0.61*
< 0.001
0.66*
< 0.001
0.67*
< 0.001
0.72*
< 0.001
0.60*
< 0.001
0.09
0.480
0.54
< 0.001
0.72*
< 0.001
0.62*
< 0.001
0.66*
< 0.001

BCTQ

*Denotes excellent-good to excellent correlations. BCTQ = Boston Carpal Tunnel Questionnaire; MHQ = Michigan Hand
Questionnaire; PROM = patient-reported outcomes measure; PROMIS = Patient-reported Outcome Measurement Information
System.

purpose. Thus, we recommend that surgeons use the
PROMIS UE and PI scales rather than the PF when electing
to use the PROMIS for evaluating patients.
Our study’s limitations should be considered when
evaluating our ﬁndings. First, the data come from a single
institution and surgeon. While there may be a question of
generalizability, we feel our ﬁndings may be applicable to
clinics with similar characteristics (such as an urban tertiary
care center). Nonetheless, validating our ﬁndings with an
independent sample would be valuable. Further work may
also evaluate whether our results are consistent with more
rural, community-based centers.
Second, we had a selection bias for two key reasons:
(1) We only included patients who presented preoperatively and at 6 weeks or 3 months postoperatively and
(2) although 101 patients were ultimately enrolled in our
study, we approached every patient with a diagnosis of
CTS and not everyone was willing to participate. It is
possible that those willing to enroll were more invested in
their care and/or had other traits or resources that would
impact PROMs. Additionally, because patients who
returned to the clinic before 6 weeks after surgery were not

included, we could be missing patients who recovered to a
greater extent. However, we feel our study was not substantially affected by these factors because this bias is
consistent across all PROMs, and we did not evaluate
clinical outcomes but the performance of one PROM
against others at the ﬁnal timepoint at which patients felt
they needed to see a hand surgeon.
Third, the study had two postoperative timepoints.
While this may have affected the size of the ESI for each
PROM because more or less time had passed for a patient to
recover, it does not substantially affect our study ﬁndings.
This is because our goal was not to evaluate clinical outcomes over time but to compare the ability of each PROM
to capture change against one other. Indeed, although the
times differ, the length of followup affects all PROMs
equally; thus, comparing responsiveness is still valid.
Fourth, the severity of CTS may vary, which could
impact the amount of possible clinical improvement.
However, similar to the third limitation, we are not as
worried about this limitation because this study did not
evaluate clinical outcomes, and all PROMs used for comparison were from the same patient population.

Lastly, our patients were informed that the PROMs
would be used for research. Although this may have impacted how the patients completed the questionnaires,
previous research on this subject has shown that patients do
not tend to change PROM answers, even if they are aware
that the scores will be used for research or clinical care [4].
Although the PROMIS UE and PI domains had acceptable responsiveness in evaluating patients with CTS undergoing CTR at the ﬁnal followup, they were not as
responsive as the MHQ and BCTQ. The PROMIS PF was
not reasonably responsive in the same patient population.
Previous research has shown that the PROMIS PF, UE, and
PI domains in patients with hand and upper-extremity disorders are responsive [17]. Indeed, the study showed large
effect sizes (ESI, 0.80-1.48) in patients with hand and upperextremity disorders [17]. These ﬁndings demonstrate that the
PROMIS domains were slightly more responsive in a general hand and upper-extremity population than in a speciﬁc
population of patients with CTS undergoing CTR. This
suggests that not all hand and upper-extremity disorders are
the same. Another study has examined how PROMIS
domains respond to CTR compared with the MHQ and
BCTQ at different timepoints postoperatively [21]. The
authors noted that the PROMIS UE had a similar but weaker
responsiveness at each postoperative timepoint (that is, the 1week, 6-week, and 3-month timepoints), while the PROMIS
PI did not respond at 1 week postoperatively but at the 6week and 3-month followup timepoints [21]. The PROMIS
PF did not demonstrate good responsiveness at any of these
timepoints [21]. Although our study differs because we
assessed responsiveness at least 6 weeks after CTR to allow
for at least moderate recovery and only at the patient’s ﬁnal
followup visit, we found similar results. Indeed, based on the
ESI values, the PROMIS UE and PI show a lower ability to
detect change in patients with CTS than the MHQ and BCTQ
did, although they were comparable. This is to be expected,
because the MHQ and BCTQ were speciﬁcally designed to
evaluate an anatomic region and disease process, while
PROMIS domains are meant to capture data on overall health.
The ﬁnding that the PROMIS UE and PI can detect change at
the ﬁnal followup visit after CTR—even moderately—in
patients with such a limited, neuropathic hand condition raises
the question of how speciﬁc a disease process can be before a
PROMIS domain does not capture change.
The PROMIS UE and PI domains demonstrated stronger correlations, in general, with the MHQ and BCTQ
domains in both the preoperative and postoperative time
periods than the PF did. Studies of patients with hand and
upper-extremity conditions showed there was concurrent
validity between the PROMIS PF and UE and DASH and
QuickDASH (the validated shortened version of the
DASH) [2, 24]. However, we did not ﬁnd that the PROMIS
PF had concurrent validity with many of the MHQ
domains, which are region-speciﬁc and similar to the

DASH and QuickDASH. This difference may be because
of our focus on a single condition and its treatment (that is,
patients with CTS undergoing CTR) or because of the type
of hand conditions we evaluated (such as neuropathic).
Given our results, we suggest using the PROMIS UE instead of the PROMIS PF in patients with CTS whenever
possible. If a generic PROM is preferred, we feel it is also
reasonable to use the PROMIS UE instead of the PROMIS
PF in patients with all types of hand and wrist conditions
until additional research is performed to determine any
differences between various hand conditions. For example,
future research is needed to determine whether our ﬁndings
would be consistent in patients with basal joint arthritis or
traumatic conditions (such as distal radius fracture) as well.
This study demonstrated that the PROMIS UE and PI are
responsive and show concurrent validity in patients undergoing CTR. Region- and disease-speciﬁc scales both
showed better responsiveness, with the MHQ Satisfaction and
BCTQ Symptom Severity scales demonstrating the highest
ESI scores. Our evaluation of concurrent validity showed that
the PROMIS UE and PI scales are acceptable for evaluating
patients undergoing CTR. However, we do not recommend
using the PROMIS PF for patients undergoing CTR because it
is not responsive and does not correlate strongly with regionor condition-speciﬁc PROMs. As expected, region- and
condition-speciﬁc PROMs tend to capture data on a speciﬁc
anatomic area or condition slightly better than general PROMs
do; however, it is promising that a global PROM competes
well with these instruments. Ultimately, using a global PROM
such as the PROMIS may be more advantageous than regionand condition-speciﬁc PROMs as we shift our focus to population health, general wellbeing, and value-based medicine.
This is because the PROMIS is normalized to the general
population and offers a more complete picture of a patient’s
overall health. There is a great opportunity in day-to-day
clinical medicine to use these PROMIS domains, as well as
others that capture more psychosocial elements of health such
as self-resiliency, to inform surgeons on a patient’s overall
health status and how best to council or treat him or her.
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